Kyverna Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VIDA VENTURES ADVISORS, LLC | 04/03/2025 | 4.52 M | $8.73 B | 0.00% | 10.47% |
GILEAD SCIENCES, INC. | 05/13/2025 | 4.13 M | $7.96 M | 0.00% | 9.55% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2025 | 3.37 M | $6.50 M | 0.00% | 7.79% |
NOVO HOLDINGS A/S | 05/15/2025 | 1.85 M | $3.57 M | 0.00% | 4.28% |
BLACKROCK, INC. | 05/02/2025 | 1.68 M | $3.24 M | 0.23% | 3.88% |
VANGUARD GROUP INC | 05/09/2025 | 1.30 M | $2.51 M | -1.13% | 3.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 993.62 K | $1.92 M | 512.14% | 2.30% |
INSIGHT HOLDINGS GROUP, LLC | 05/15/2025 | 989.05 K | $1.91 M | 8.34% | 2.29% |
FRANKLIN RESOURCES INC | 05/13/2025 | 692.03 K | $1.34 M | 0.00% | 1.60% |
MBB PUBLIC MARKETS I LLC | 05/16/2025 | 614.48 K | $1.19 M | 0.00% | 1.42% |
05/15/2025 | 586.91 K | $1.13 M | 0.00% | 1.36% | |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 579.60 K | $1.12 M | -2.37% | 1.34% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 563.97 K | $1.09 M | 4.50% | 1.31% |
04/30/2025 | 396.22 K | $764.71 K | 100.00% | 0.92% | |
04/02/2025 | 376.19 K | $726.04 K | 0.01% | 0.87% | |
STATE STREET CORP | 05/15/2025 | 374.58 K | $722.94 K | -1.40% | 0.87% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 238.24 K | $459.80 K | -68.09% | 0.55% |
NORTHERN TRUST CORP | 05/13/2025 | 191.66 K | $369.91 K | -2.06% | 0.44% |
SUPERSTRING CAPITAL MANAGEMENT LP | 05/15/2025 | 191.29 K | $369.18 K | 5.00% | 0.44% |
UBS GROUP AG | 05/13/2025 | 177.67 K | $342.90 K | -12.65% | 0.41% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 165.37 K | $319.16 K | -2.60% | 0.38% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 136.30 K | $263.06 K | 70.38% | 0.32% |
MORGAN STANLEY | 05/15/2025 | 134.91 K | $260.38 K | -32.74% | 0.31% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 124.96 K | $241.17 K | 179.55% | 0.29% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 122.98 K | $237.35 K | -32.30% | 0.28% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 104.46 K | $201.61 K | -7.94% | 0.24% |
TD ASSET MANAGEMENT INC | 05/07/2025 | 90.24 K | $174.17 K | 0.00% | 0.21% |
BARCLAYS PLC | 05/15/2025 | 81.39 K | $157.00 K | -9.15% | 0.19% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 80.90 K | $156.14 K | 0.76% | 0.19% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 71.06 K | $137.14 K | 100.00% | 0.16% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 68.63 K | $132.45 K | 31.07% | 0.16% |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 67.55 K | $130.36 K | 54.35% | 0.16% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 48.78 K | $94.15 K | 22.16% | 0.11% |
05/12/2025 | 47.51 K | $91.69 K | 100.00% | 0.11% | |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 46.38 K | $89.52 K | 3.11% | 0.11% |
JPMORGAN CHASE & CO | 05/12/2025 | 39.50 K | $76.24 K | -98.18% | 0.09% |
STIFEL FINANCIAL CORP | 05/14/2025 | 39.16 K | $75.59 K | -0.46% | 0.09% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 38.60 K | $74.50 K | 2.14% | 0.09% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 37.83 K | $73.01 K | -86.22% | 0.09% |
FEDERATED HERMES, INC. | 05/08/2025 | 36.00 K | $69.48 K | 12.50% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 34.45 K | $66.49 K | 174.02% | 0.08% |
ALPS ADVISORS INC | 04/30/2025 | 32.13 K | $62.00 K | -7.98% | 0.07% |
RHUMBLINE ADVISERS | 05/29/2025 | 31.61 K | $61.01 K | 21.97% | 0.07% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 30.01 K | $57.92 K | 0.00% | 0.07% |
SEI INVESTMENTS CO | 05/14/2025 | 24.66 K | $47.59 K | 100.00% | 0.06% |
MARSHALL WACE, LLP | 05/15/2025 | 24.56 K | $47.40 K | 61.15% | 0.06% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 21.95 K | $42.35 K | 100.00% | 0.05% |
CITIGROUP INC | 05/12/2025 | 19.15 K | $36.97 K | -5.77% | 0.04% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 17.33 K | $33.44 K | -20.48% | 0.04% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 16.68 K | $32.19 K | -90.68% | 0.04% |
Kyverna Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 94 institutional investors and hedge funds held shares of Kyverna Therapeutics, Inc.. The most heavily invested institutionals were:
Vida Ventures Advisors, LLC: 4.52 M
GILEAD SCIENCES, INC.: 4.13 M
Bain Capital Life Sciences Investors, LLC: 3.37 M
Novo Holdings A/S: 1.85 M
BlackRock, Inc.: 1.68 M
VANGUARD GROUP INC: 1.3 M
59.67% of Kyverna Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.14 M shares in the last 24 months. This purchase volume represents approximately $81.90 M in transactions.